Hepatic CT perfusion CT for the therapeutic response of sorafenib for hepatocellular carcinoma
Phase of Trial: Phase IV
Latest Information Update: 29 Aug 2018
Price : $35 *
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 23 Aug 2018 Status changed from active, no longer recruiting to completed.
- 23 Aug 2016 Status changed from not yet recruiting to active, no longer recruiting.
- 22 Aug 2013 New trial record